The health industry might be lacking in overall digital maturity, but it’s making up for it with a willingness to explore newer formats and ways of connecting. Never before have health marketers had such a great opportunity to refocus and improve on how to connect with healthcare professionals and their patients.

Healthcare marketers are bracing for another disruptive year. From the legislative shifts coming out of Washington to CVS merging with Aetna to ever-changing advancements in the digital space, there’s a lot for healthcare brands to stay on top of.

Pharma marketing departments are no longer just responsible for bringing in new subscribers. They are now tasked with managing the entire customer experience, starting from the initial interaction to establishing and maintaining a loyal brand relationship.

As leading media minds bustled into Google’s NYC Chelsea Tech Talk room on October 19th, a shared question weighed on everyone’s mind, “How do I adapt and excel as the world around me is changing?” Executives in the room represented ABC, AT&T, Comcast, A&E, Verizon, Lionsgate, amongst others.

What can CVS Health patients, Aetna members and marketers expect as a result of the proposed merger, and what's on the horizon beyond this momentous deal?

If you follow B-to-B marketing buzz, you’ve probably noticed that account-based marketing (ABM), a one-to-one engagement approach, is getting some serious attention.

With the role of the pharma rep in decline, it’s critical for pharma companies to reinvent that role, especially as the industry shifts toward a people-based marketing framework that’s rooted in customer centricity. Integral to this shift is the concept of the rep as a franchisee.

Given the rapidly evolving changes to our healthcare system, as well as the overwhelming volume of content that healthcare professionals (HCP) are faced with daily across channels, a defined HCP communication strategy at the therapeutic and brand level is more important than ever for the pharmaceutical industry. To compete in this dynamic and over-saturated market, pharma companies must shift their approach to focus less on the individual campaign and more on an enterprise-wide strategy that places the customer at the center of the business.